Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2009 | -821.4% | -8,239.4% | -8,103.1% |
| FY2010 | 103.3% | -451.2% | -436.6% |
| FY2011 | 17.2% | -435.6% | -435.6% |
| FY2012 | 75.4% | -34.9% | -33.3% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2009 | -821.4% | -8,239.4% | -8,103.1% |
| FY2010 | 103.3% | -451.2% | -436.6% |
| FY2011 | 17.2% | -435.6% | -435.6% |
| FY2012 | 75.4% | -34.9% | -33.3% |